Processing

Please wait...

Settings

Settings

Goto Application

1. WO2004101585 - MACROLIDES SUBSTITUDED AT THE 4'-POSITION

Publication Number WO/2004/101585
Publication Date 25.11.2004
International Application No. PCT/EP2004/005081
International Filing Date 11.05.2004
IPC
C07H 17/08 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
17Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
04Heterocyclic radicals containing only oxygen as ring hetero atoms
08Hetero rings containing eight or more ring members, e.g. erythromycins
CPC
A61P 31/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
C07H 17/08
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
17Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
04Heterocyclic radicals containing only oxygen as ring hetero atoms
08Hetero rings containing eight or more ring members, e.g. erythromycins
Applicants
  • GLAXO GROUP LIMITED [GB]/[GB] (AllExceptUS)
  • PLIVA - ISTRAZIVACKI INSTITUT D.O.O. [HR]/[HR] (AllExceptUS)
  • ALIHODZIC, Sulejman [HR]/[HR] (UsOnly)
  • BERDIK, Andrea [HR]/[HR] (UsOnly)
  • BERGE, John, Michael [GB]/[GB] (UsOnly)
  • JARVEST, Richard, Lewis [GB]/[GB] (UsOnly)
  • MUTAK, Stjepan [HR]/[HR] (UsOnly)
Inventors
  • ALIHODZIC, Sulejman
  • BERDIK, Andrea
  • BERGE, John, Michael
  • JARVEST, Richard, Lewis
  • MUTAK, Stjepan
Agents
  • GLADWIN, Amanda, Rachel
Priority Data
0310984.013.05.2003GB
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) MACROLIDES SUBSTITUDED AT THE 4'-POSITION
(FR) MACROLIDES SUBSTITUES EN POSITION 4''
Abstract
(EN) The present invention relates to 14- or 15-membered macrolides substituted at the 4' position of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infections in a human or animal body.
(FR) La présente invention concerne des macrolides à 14 ou 15 éléments substitués en position 4'', représentés par la formule (I), ainsi que des dérivés pharmaceutiquement acceptables de ces composés et leurs procédés de préparation et d'utilisation dans le traitement et la prévention d'infections microbiennes systémiques ou locales chez l'homme ou l'animal.
Related patent documents
IN02194/KOLNP/2005This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
IN2194/KOLNP/2005This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
US2007213283This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
Latest bibliographic data on file with the International Bureau